Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Operating cash flow minus capital expenditures
Percentile
P13
Within normal range
vs 3Y Ago
-3x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-25.04M | +24.3% |
| 2024 | $-33.08M | +30.3% |
| 2023 | $-47.49M | -673.7% |
| 2022 | $8.28M | +139.4% |
| 2021 | $-21.00M | +4.0% |
| 2020 | $-21.87M | -1.6% |
| 2019 | $-21.53M | -4.2% |
| 2018 | $-20.67M | +4.2% |
| 2017 | $-21.58M | -3.5% |
| 2016 | $-20.85M | - |